About iReminder — a Patient-centric Reminder System
About 1.6 billion prescriptions are written
every year in the United States. Only 50% of patients
who suffer from chronic diseases are medication compliant.
The greatest decline in adherence is in the first six
months. One study tracking statin prescription refills
in 4,802 patients determined that, on average, patients
were missing at least 20% of their doses. Non-compliance
saddles employers, government and pharmaceutical sectors
with $100 billion in direct costs.
Compliance for Life™
(CFL) was developed by iReminder, LLC, a healthcare
technology company. It is an automated notification
system designed to improve medication compliance and
persistence. Research shows that the vast majority of
people want to take their medication but, given their
busy lives, chronic conditions, and complex regimens,
they simply forget to do so. We believe that self-reminders
and reminders from family members and trusted caregivers
are the most effective means of improving compliance
rates.
Compliance for Life complements
other reminder systems, including nurse call centers,
prescription refill notices, wearable devices and healthcare
incentive programs. It is an effective compliance tool
for Baby Boomers taking care of themselves or their
elderly parents, older adults in independent living
situations, parents taking care of an ill child, and
individuals managing acute or chronic illness.
Studies show that the most effective reminders are
those that are the least disruptive to the patient and
require minimal behavior modification. Compliance
for Life enables individuals to use
the telephone or the Internet to set up and receive
reminders, to take and refill medication, go to the
doctor, take medical tests and perform other medically-necessary
tasks.
Users access Compliance for Life and set up reminders by either going to
a web site or making a phone call. Those making
phone calls dial into CFL’s system where an Interactive
Voice Response (IVR) system, using automated speech
recognition, guides users through creating, editing
and canceling reminders. The use of a phone interface
to set up reminders is unique to CFL and opens its use
not only to tech-savvy individuals but also to those
who are not comfortable using a computer.
Compliance for Life conforms
to HIPPA regulations. It is a 100% opt-in system. To
ensure security and eliminate unwanted reminders, all
contacts - users, family members, and caregivers - must
agree to accept reminders and confirmations.
Mission
iReminder's mission is to increase revenues and profitability
for our clients in the healthcare industry by motivating
patients to increase compliance and persistence with
their prescribed medications. Our goal is to control
and ultimately reduce healthcare costs by developing
reliable tools that help people manage their own personal
health and the health of those for whom they provide
care.
Key Features
With Compliance for Life, users
can:
- Create, edit and cancel reminders by telephone or
online.
- Record the reminder in the patient’s or a
loved one’s voice.
- Set a delivery sequence.
- Receive reminders via phone, email or text message.
- Select a contact person who will be alerted if the
reminder is not received or the recipient cannot comply
with reminder.
- Receive medication regimen instructions and educational
messages.
- Broadcast messages to multiple members of a users
"network."
Business Model
Compliance for Life is marketed
to large employers, payers, disease management firms,
pharmacy benefit managers, managed care organizations,
pharmaceutical manufacturers and distributors, and pharmacy
chains that, in turn, will distribute CFL to their constituents. Other
targets are federal government agencies, technology
content providers, labor unions, and state retirement
benefits organizations. CFL can be licensed at
an enterprise level or on an annual basis. It
also can be purchased on a Software as a Service (SaaS)
basis. Licensees have the option of hosting CFL
on their own or third-party servers and may brand the
system.
|